Translated title of the contribution: Non-monoaminergic systems in schizophrenia

B. N M Van Berckel*, J. M. Van Ree, R. S. Kahn

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review


In the past, schizophrenic research has focussed on mono-aminergic systems, particularly dopaminergic systems. Less is known about the contribution of non-monoaminergic systems in the pathology of schizophrenia. The significance of non-monoaminergic systems, like excitatory aminoacids, cholecystokinin, σ-receptors and γ-type endorphins, for schizophrenia research are discussed. Several trials have been performed with cholecystokinin and γ-type endorphins. The results of open and single blind experiments with these peptides were promising. However the outcome of the first double-blind, placebo-controlled, studies were less positive. In both cases there are not enough double-blind, placebo-controlled studies available to give a definite judgement about the role of these peptiden in the pathology of schizophrenia. Far less studies have been done with σ-receptors antagonists and excitatory aminoacids. Therefore more trials with σ-receptors antagonists and excitatory aminoacids are needed to establish the role of these systems in the pathology of schizophrenia.

Translated title of the contributionNon-monoaminergic systems in schizophrenia
Original languageDutch
Pages (from-to)762-775
Number of pages14
JournalTijdschrift voor Psychiatrie
Issue number10
Publication statusPublished - 1 Jan 1994

Cite this